Antibodies positive for P.1 variants in LTC residents

Published Date: 16 Feb 2023

How is the SARS-CoV-2 mRNA antibody similar to the P.1 gamma strain and other strains?

Read Full News

Latest News

One Food, Every Meal – What Does This Do to the Gut?

With the mono diet, patients eat only one food. Dr Alicia Muratore explains the lack of data behind it and offers recommendations for talking to patients.

GLP-1s Slash Obesity-Related Cancer Risk

Prof David Kerr reviews a new study published in Annals of Oncology tracking how GLP-1 receptor agonists significantly slashed the short-term incidence of 13 tumor types.

FemTech’s Biggest Test: Can It Deliver on Its Promise?

Wearables and advanced algorithms are expanding FemTech beyond fertility tracking, but scientific validation, regulation, and privacy remain essential for clinical adoption.

US Adults Prefer Longer Antibiotic Courses

Many US adults prefer longer courses and rate them safer and more effective than shorter courses.

Bacterial Vaginosis Linked to Higher Risk for STIs

Women with bacterial vaginosis face substantially elevated odds of concurrent chlamydia, gonorrhea, trichomoniasis, and mycoplasma infections.

US Women Unsure When, How to Seek Perimenopause Treatment

The survey study finds prevalent uncertainty about perimenopause in US women; an expert says that’s because the diagnosis isn’t real.

Todays Updates

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Todays Updates

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Latest News

With the mono diet, patients eat only one food. Dr Alicia Muratore explains the lack of data behind it and offers recommendations for talking to patients.

Prof David Kerr reviews a new study published in Annals of Oncology tracking how GLP-1 receptor agonists significantly slashed the short-term incidence of 13 tumor types.

Wearables and advanced algorithms are expanding FemTech beyond fertility tracking, but scientific validation, regulation, and privacy remain essential for clinical adoption.

Many US adults prefer longer courses and rate them safer and more effective than shorter courses.

Women with bacterial vaginosis face substantially elevated odds of concurrent chlamydia, gonorrhea, trichomoniasis, and mycoplasma infections.

The survey study finds prevalent uncertainty about perimenopause in US women; an expert says that’s because the diagnosis isn’t real.

News All Time

GP Follow-Up Tied to Higher Cervical Surveillance Loss

Patients with cervical precancerous lesions followed by general practitioners showed higher rates of missed surveillance appointments than those monitored by gynecologists.

EMA Recommends New Hematology and Supportive Care Drugs

Ruxolitinib Viatris and Cavoley moved closer to EU approval, offering a bioequivalent option for hematologic disease and a biosimilar to help prevent chemotherapy-related febrile neutropenia.

Children Lose More Weight With Family-Based Treatment

A randomized trial found adding a family-based component to a weight management program for children in primary care resulted in greater reduction in body mass index.

FDA Approves First NDSRI for ADHD in Adults and Children

The FDA has approved Simtriyo (centanafadine) as the first norepinephrine, dopamine, serotonin reuptake inhibitor for adult and pediatric ADHD.

S4 Episode 6: Can Diet Improve Psoriasis Outcomes?

Many patients ask whether changing what they eat can help their psoriasis. Dr Joel Gelfand reviews the MEDIPSO trial and explains when a Mediterranean diet may meaningfully improve disease severity.

What Algorithms Cannot Heal: The Future of Rural Dermatology

Geographic barriers delay diagnoses, worsen outcomes, and increase morbidity from inflammatory skin disease and mortality from skin cancer, and patients often travel hours for specialty care.

Frailty Tied to Complications After Incontinence Surgery

Frailty is associated with complications and mortality within a year after stress urinary incontinence surgery in older men.

Guideline Update: Thyroid Disease in Pregnancy

Drs Kaniksha Desai and Angela Leung discuss the new guidelines for thyroid disease in preconception, pregnancy, and postpartum.

Starting Over: What Changing Practices Taught Me About Trust

Vaccine hesitancy and misinformation get the blame for declining patient trust, but Dr Kenny Lin argues a major factor is being overlooked: disappearing continuity of care.

MRI Staging Matches DRE Accuracy in Prostate Cancer Survival

A multicentre study shows that MRI-based local T staging provides risk discrimination similar to digital rectal examinations for clinically localised or locally advanced prostate cancer.

Radiation Deserts Grow as Rural Radiation Sites Are Lost

More than 50 million Americans live in counties without a radiation oncology practice site as rural and community-based centers disappear at higher rates.

Drinking Water Contaminants Tied to Uterine Cancer Risk

A large study links long-term exposure to disinfection byproducts in drinking water to uterine cancer, but experts stress the limitations of the data.

Traffic Noise a Novel Parkinson’s Risk Factor?

Long-term exposure to loud traffic noise may be a novel environmental risk factor for Parkinson’s disease, a new study suggests.

Hearing Checks Boost Detection of Cytomegalovirus in Infants

The findings underscore why many experts are still pushing for universal screening.

First MS Mobility Drug Gets Green Light From NHS England

NHS England reverses a 2022 NICE rejection now fampridine is off patent, bringing England into line with the rest of the UK.

Pharmacies Left Out as Pubs Get Rates Cut

Pharmacy associations criticise the government's decision to offer another business rates cut to pubs and live music venues while excluding high street pharmacies again.

Recommended News For You

Alkem introduces cetuximab under the trade name Cetuxa in India.

Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

Telemedicine services linked to reducing excess mortality

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

Atezolizumab Consolidation Impresses in High-Risk DLBCL

Recommended Articles For You

Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics 

The Power of White Blood Cells: How They Help Keep Us Healthy 

Advanced Directions in Oncology and Quality Improvement 

Childhood Cancer Survivorship and Long-Term Organ Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel Agent for Chronic GVHD Wins FDA Approval

2.

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

3.

Including Bereavement in the Care Continuum.

4.

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

5.

Taking Charge of Your Cancer Journey.

1.

Breaking Barriers: Innovative Approaches in Brain Tumor Treatment

2.

A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer

3.

The Capmist DM: A Revolutionary Way to Combat Dry Mouth

4.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

5.

Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part XII

2.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

3.

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

5.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot